The 22-city rollout, which begins in Mumbai early next month, will go national in a phased manner. In the long run, the company plans to offer these services across tier-1 and tier-2 cities, sources said.
Five pilot projects are under way in Mumbai to understand the patient pool and set up chronic care infrastructure. The projects are on at Andheri (W), Khar, Nerul (Navi Mumbai), Bandra and Vile Parle, sources said.
A Medybiz spokesperson declined to comment on the pilots, but said, "In a country like India where there are limited resources catering to health and competing demands, not all conditions can be treated and not every intervention provided at public expense. Here, disease management services will act as an effective healthcare delivery tool.''
The concept, highly popular in the West where it was introduced by insurance companies as a preventive care measure, would aim to improve outcomes for chronically ill and high-risk patients. The programme is based on the module of a unique partnership between the physician and the patient and serviced by a panel of medical and paramedical professionals.
Medybiz will focus on 12 chronic ailments as part of its portfolio, some of which will be diabetes, arthritis, asthma, chronic lung disease, cancers, heart diseases and Parkinson's.
With fees starting from as low as Rs 1,200 to Rs 1,700 a month, the patient-centric service model will have all services practically provided at the patient's doorstep, including delivery of medication.
The disease management service is an addition to Reliance's ambitious plans for its healthcare business, which already caters to medical insurance and the hospital business.
To take this further, Medybiz is in talks for a strategic tie-up with insurance majors for specialised products. The company is also keen to launch a geriatric care vertical in addition to its chronic ailment business, and aims to tap a senior citizen population of 85 million.

No comments:
Post a Comment